Form 4: Solid Biosciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Ian F Smith, a Director of Solid Biosciences Inc., reported multiple transactions in common stock on October 2, 2026.
Summary
- Option exercise/conversion: acquired 3,440 Common Stock on October 2, 2026; holds 141,585 after (Direct).
- Option exercise/conversion: disposed of 3,440 Restricted Stock Units on October 2, 2026; holds 3,440 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ian F Smith — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Option exercise/conversion | Common Stock | 3,440 | — | — | 141,585 |
| 2026-10-02 | Option exercise/conversion | Restricted Stock Units | 3,440 | — | — | 3,440 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Option exercise/conversion (3,440 shares) |
| 2026-10-02 | Option exercise/conversion (3,440 shares) |
Keywords
insider transaction, Form 4, SLDB, Solid Biosciences Inc., neutral, Ian F Smith
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.